Home
Home » companies

Amgen

Four Factors Driving Amgen's Stock Price To $102

Four Factors Driving Amgen's Stock Price To $102
Seeking Alpha

Amgen's And Vical's Melanoma Trials: Questions

Amgen's And Vical's Melanoma Trials: Questions
Seeking Alpha

Recent Melanoma Trial Data Has Biotech Stocks Moving

Recent Melanoma Trial Data Has Biotech Stocks Moving
Seeking Alpha

Modified Cold Sore Virus Shrinks Melanoma Tumors, Amgen Says

Modified Cold Sore Virus Shrinks Melanoma Tumors, Amgen Says
Forbes

Does Amgen's Dividend Have Room to Soar?

Does Amgen's Dividend Have Room to Soar?
Motley Fool

Agilent And The Boom In Companion Diagnostics

Agilent And The Boom In Companion Diagnostics
Seeking Alpha

Yet Another Negative Trial For Amgen's Aranesp

Yet Another Negative Trial For Amgen's Aranesp
Forbes

Amgen And The Biosimilar Threat: Lessons From Affymax

Amgen And The Biosimilar Threat: Lessons From Affymax
Seeking Alpha

Merck's Big Vytorin Study Could Pose A Challenge For Amgen, Sanofi, And Regeneron, Too

Merck's Big Vytorin Study Could Pose A Challenge For Amgen, Sanofi, And Regeneron, Too
Forbes

Merck names ex-Amgen exec to run R&D

Merck names ex-Amgen exec to run R&D
Yahoo/AP